Increasing Chlamydia Screening in the High-Risk Population using Electronic Notification and Targeted Education: A Primary Care Approach by Barnett, Michael
The University of San Francisco 
USF Scholarship: a digital repository @ Gleeson Library | Geschke 
Center 
Doctor of Nursing Practice (DNP) Projects Theses, Dissertations, Capstones and Projects 
Spring 5-1-2021 
Increasing Chlamydia Screening in the High-Risk Population using 
Electronic Notification and Targeted Education: A Primary Care 
Approach 
Michael Barnett 
University of San Francisco, mbarnett@usfca.edu 
Follow this and additional works at: https://repository.usfca.edu/dnp 
 Part of the Nursing Commons 
Recommended Citation 
Barnett, Michael, "Increasing Chlamydia Screening in the High-Risk Population using Electronic 
Notification and Targeted Education: A Primary Care Approach" (2021). Doctor of Nursing Practice (DNP) 
Projects. 261. 
https://repository.usfca.edu/dnp/261 
This Project is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at 
USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in 
Doctor of Nursing Practice (DNP) Projects by an authorized administrator of USF Scholarship: a digital repository @ 
Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu. 





Increasing Chlamydia Screening in the High-Risk Population using Electronic Notification and 










Michael Barnett, DNP(c), MS, CNS-BC, CEN 
N789 – DNP Product 
University of San Francisco  
Chair: Jodie Sandhu DNP, FNP-C, PA-C, CNL 




INCREASING CHLAMYDIA SCREENING IN PRIMARY CARE 2 
Abstract 
The primary care office is an ideal setting and the front gate for screening young adults 
for chlamydia infection.  Chlamydia is the most common sexually transmitted infection in the 
US and sexually active women aged 24 and younger are at the highest risk for having it (Centers 
for Disease Control and Prevention [CDC], 2016).  Screening is simple and effective and can be 
completed through a urine test.  Treatment is straightforward and involves a one-time dose of 
antibiotic medicine. Untreated infections in women can lead to pelvic inflammatory disease 
(PID), chronic pelvic pain, infertility, and life-threatening ectopic pregnancies (Papp, Schachter, 
Gaydos, & Pol, 2014).  Despite the simplicity of managing this specific sexually transmitted 
infections, screening occurs in only about half of these women (CDC, 2013).  The advent of the 
electronic medical record (EMR) has helped to improve healthcare, for example medication 
errors have drastically improved (The Office of the National Coordinator for Health Information 
Technology, (ONC), 2019).  For my DNP project, I leveraged the technologic potential of the 
EMR’s in order to improve chlamydia screening.  This technology stands to identify more 
infections and earlier, facilitate prompt treatment with a simple and cheap medication, improve 
the quality of lives of US citizens, and preserve precious healthcare resources by reducing the 
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Problem Description 
Chlamydia is the most common sexually transmitted infection reported in the United 
States and it is estimated that 1 in every 20 sexually active females aged 13 to 24 is infected 
(Torrone, Papp, Weinstock, & Centers for Disease Control and Prevention, [CDC], 
2014).  Chlamydia is a bacterial infection that is often asymptomatic, thus most of those infected 
are unaware and do not seek treatment, while being able to spread it silently.  In 2012 there were 
more than 1.4 million cases that were reported to the CDC, however, because most infections are 
asymptomatic the true incidence is hard to accurately estimate (Centers for Disease Control and 
Prevention, 2015).  There is a disproportionate amount of infection in minorities as well as those 
in low socioeconomic status (Owusu-Edusei, Chesson, Leichliter, Kent, & Aral, 2013).  
Untreated infections in women can lead to pelvic inflammatory disease, chronic pelvic pain, 
infertility, and life-threatening ectopic pregnancies (Papp, Schachter, Gaydos, & Pol, 2014).   
People between the ages of 13 and 24 years old are considered to be in adolescence and 
early adulthood.  This period of life includes physical, psychological, cognitive, emotional, 
social, sexual, and identity development within the framework of social expectations, change, 
and increased risk-taking (Jaworska & MacQueen, 2015).  Behaviorally, adolescents are more 
likely to engage in high-risk sexual behavior such as concurrent sex partners or sex without a 
condom.  This is due in part to the fact that the prefrontal cortex, responsible for executive 
function, is still developing through adolescence (Shannon & Klausner, 2018). Furthermore, 
experts in the field of adolescent health have long recognized that many of the greatest threats to 
health and wellness for this population occurs as a result of risky behaviors, including unsafe sex 
(resulting in high rates of unplanned pregnancies as well as sexual transmitted disease) (Bitzer, 
Sultan, Creatsas, & Palacios, 2014). Early adulthood is the transition period between adolescence 
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and adulthood and is important as it sets the stage for later adult life.  Young adults (aged 19 to 
24) often develop healthy lifestyles but are not risk-free. Identified risks include the use of 
alcohol, tobacco, and drugs (and driving under the influence) and risky sexual behavior persists 
from adolescence and even peaks in this age period (Scales et al., 2015).  This results in males 
and females, aged 24 years old and younger, being at an increased risk for acquiring chlamydia. 
The United States Preventive Services Task Force (USPSTF) is an independent group of 
national experts who research and develop recommendations for clinical preventive 
services.  Their mission is to provide evidence-based recommendations on preventive services to 
primary care physicians who deliver preventive care (Krist, Bibbins-Domingo, Wolff, & Mabry-
Hernandez, 2018).  One of the recommendations put forth by the USPSTF is to perform annual 
chlamydia screening for all sexually active females aged 24 and younger (USPSTF, 
2014).  Several other professional organizations have developed and endorse similar screening 
guidelines (Table 1).  Based on these recommendation Medicare, Medicaid, and private health 
insurance plans cover the cost of screening and treatment without cost-sharing (CDC, 2020). 
 
Table 1 - Recommendations for Chlamydia Screening 
Organization Recommendations 
United States Preventive Services Task Force 
Screen annually for all sexually active females aged 24 
years and younger 
The Centers for Disease Control and Prevention 
Screen annually for all sexually active females aged 25 
years or younger 
American Academy of Family Physicians 
Screen annually for all sexually active females aged 24 
years and younger  
American College of Obstetricians and Gynecologists 
Screen annually for women younger than 25 
  
American Academy of Pediatrics 
Screen annually for women younger than 25 
 
 
According to the American Academy of Family Physicians (AAFP), primary care 
practice provides health promotion, disease prevention, health maintenance, counseling, patient 
education, diagnosis and treatment of acute and chronic illnesses within a variety of care settings 
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(American Academy of Family Physicians, 2020).  Despite primary care being the responsible 
and optimal setting, effective patient screening for targeted populations can be challenging 
within a busy primary care setting. Primary care appointments are typically 15 minutes in 
duration, and the majority of appointment include either a chronic condition or a new complaint 
(CDC, 2019).  Insurance data from 2014 reflects this challenge showing that only 47% of 
sexually active women under the age of 24 with commercial health insurance and about 55% 
with Medicaid were screened for chlamydia (CDC, 2013).   
Native American Health Center (NAHC) is a Federally Qualified Health Center (FQHC) 
located in the Fruitvale area of Oakland, California.  An FQHC is a community-based 
organization that provides comprehensive primary and preventative care, including health, oral, 
and mental health/substance abuse services to all people regardless of health insurance status or 
ability to pay (Rural Health Information Hub, 2019).  The FQHC is considered a critical 
component of the health care safety net and functions to provide services to underserved 
populations.  Native American Health Center is a primary care outpatient community clinic that 
serves a diverse urban population.  This population consists of: 21% Native American, 20% 
African American, 47% Latino, 12% Euro American, 9% Asian/Pacific Islander, and 1% 
unknown (Native American Health Center, 2010).  The languages spoken at the clinic include 
English, Spanish, Mam, Chinese, and Tongan.   
A needs assessment was performed at NAHC in May 2019 with chlamydia screening 
rates being evaluated for the years of 2018 to 2019.  Screening rates for this high-risk and 
underserved population of sexually active females aged 24 and younger was found to be 14%, 
whereas the national average based on Medicare data in this population is 55%.  A GAP analysis 
reveals three areas where the current state of the organization does not reflect best practice.  
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First, staff knowledge and confidence regarding interaction with patients around the topic of 
chlamydia screening is questionable and there is lack of evidence that periodic education on 
screening guidelines, symptoms, treatment, and common questions is being provided.  Best 
practice would involve periodic education for staff members to raise awareness and knowledge.  
A solution to this gap would be to develop and provide an education module for staff to teach, 
reinforce, and update knowledge regarding aspects of care surrounding screening and treatment.  
Second, there are cultural and educational barriers with patients on effective chlamydia screening 
in the clinical setting.  Best practice would be for staff to effectively communicate and educate, 
answers questions about, and recommend annual screening to high-risk patients.  A solution to 
this gap involves creating a survey to assess staff knowledge and confidence surrounding the 
topic of chlamydia, and to conduct a secondary post-education survey to reassess staff 
knowledge and confidence after the educational content has been provided.  Finally, there is an 
absence of any formal system to remind providers of high-risk populations and frequency for 
chlamydia screening.  Best practice includes the availability of a convenient and accessible 
reminder system for staff to reference and identify high-risk populations as well as chlamydia 
screening guidelines.  A solution for this gap involves the initiation of an electronic 
notification/reminder system to alert providers when clinic patients are considered high-risk and 
due for chlamydia screening.  The aim of this project, referred to as the Chlamydia Screening 
Improvement Project (CSIP), is to improve screening rates for chlamydia infection within a 
primary care setting, by implementation of an electronic notification system and education-based 
protocol, for the high-risk patient population of sexually active females aged 24 years old and 
younger.  
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Available Knowledge 
The search inquiry was completed utilizing the electronic medical databases PubMed, 
CINAHL Complete, Scopus, and included the keywords “chlamydia”, “screening”, and “primary 
care”.  Inclusion criteria were set to include only research conducted over the past 10 years (June 
2010 through June 2020), English-language studies, peer-reviewed journals, and article types 
that included systematic reviews, randomized controlled trials, and reviews.  The search was 
conducted using the described keywords with appropriate filters yielded 301 articles.  Articles 
whose title and abstract were based on retesting after infection and treatment, partner 
notification, protocols for screening, opportunistic testing, qualitative-based articles, testing in 
the home or Emergency Departments setting, or whose focus was on men or transgender were 
excluded.  Secondary review included the reference lists in articles that met search criteria. 
Furthermore, guidelines for chlamydia screening were reviewed through a general internet search 
of qualifying organizations.  The Johns Hopkins Nursing Evidence-Based Practice Evidence 
Appraisal Tool (JHNEBP) was utilized to ascertain clinical relevance and validity.  Seven 
articles were identified for the following review of evidence and a summary of these articles are 
provided in evaluation table format (Appendix C). 
Keegan, Dledrich, & Pelpert (2014) conducted a meta-analysis that evaluated screening 
recommendations, screening tests, barriers to screening, and management for chlamydia 
infection.  There were two randomized controlled trials reviewed in this meta-analysis that 
supported annual chlamydia screening.  The first looked at high-risk women in Seattle and found 
that the risk of pelvic inflammatory disease (PID) was reduced by 50% in women who 
completed screening, and treatment, if necessary, within a one-year period.  The other looked at 
high school students in Denmark who were mailed information on chlamydia, and encouraged to 
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visit their physician for free screening.  This intervention was associated with a 50% reduced risk 
of PID (4.2% vs. 2.1%, P = 0.045) at one year.  Keegan, Dledrich, & Pelpert (2014) noted that 
based on these two studies, in 2007 the US Preventative Services Task Force (USPSTF) 
recommended annual chlamydia screening for all sexually active non-pregnant females aged 24 
and younger.  There are different methods to test for chlamydia infection. It was noted that cell 
culture was once the gold standard in identification based on its superior specificity, however, 
the current standard diagnostic and screening test has changed to nucleic acid amplification test 
(NAATs).  The use of NAATs has superior sensitivity and specificity while allowing for 
additional screening options, such as urine collection and vaginal swab. The vaginal swab 
method of testing had the highest sensitivity (86% and 97.2%), is the most preferred by patients, 
and is now the CDC recommendation for testing method (Keegan, Dledrich, & Pelpert (2014). 
While screening rates have increased over the years, potentially due to the development of 
NAAT allowing for urine or vaginal swab testing, a large portion of women are still not being 
screened.  
Barriers to screening were evaluated by Keegan, Dledrich, & Pelpert (2014) and for 
providers barriers identified included being a male provider, having the perception that 
chlamydia prevalence was low, being a solo practitioner, practicing in a rural setting, and 
practicing in an area with few minority patients.  This meta-analysis found that a combination of 
educational outreach and financial incentive increased practitioner’s involvement with chlamydia 
screening and led to a significant increase in the number of tests performed.  For patients, 
barriers to screening included a lack of knowledge related to its asymptomatic nature, possible 
long-term morbidity of infection, as well as stigma related to screening and receiving a positive 
diagnosis.  Furthermore, it was found that patients who were minority race/ethnicity, low socio-
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economic status, and lack of insurance had decreased screening.  Mail-based chlamydia 
information with a mail-back sampling kit were 2 to 3 times more likely to be diagnosed and 
treated for chlamydia than those receiving the usual standard of care.  Also, the advent of NAAT 
testing has allowed for alternative testing options (i.e. urine and vaginal swab), which was found 
to be much more comfortable for patients, allowed for self-collection, and can be done either at 
home or in the clinic.  
Treatment of infection was evaluated by Keegan, Dledrich, & Pelpert (2014) and looked 
at treatment from a medication as well as a partner-treatment standpoint.  It found that both 
azithromycin and doxycycline have comparable cure rates.  While azithromycin is a one-time 
oral treatment, doxycycline requires pills to be taken twice daily for 7 days.  Based on the 
concern that many patients may not complete all seven days of a course of doxycycline, the CDC 
recommends the use of 1 gram of azithromycin orally in a single dose (CDC, 2016).  Alternative 
treatments with erythromycin or fluoroquinolones are available for patients who are allergic to, 
or unable to tolerate, preferred treatment.  A thorough sexual history should be performed on all 
patients screening positive for chlamydia and when the patient receives a prescription for 
treatment, additional medication should be provided for treatment of all sexual contacts within 
the preceding 60 days.  The provision for providing additional prescriptions and medication 
instructions for patients to give to their sexual partners without requiring them to be seen by a 
physician is the cornerstone of Expedited Partner Therapy (EPT).  Currently, the use of EPT is 
legal in the state of California and may be provided by physicians, nurse practitioners, certified 
midwives, and physician assistants (CDC, 2007).  Reinfection is very common, for reasons 
including re-infection from untreated partners, infection from subsequent partners, persistent 
infection, and failure to complete treatment (Heijne, Althaus, Herzog, Kretzschmar, & Low, 
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2011).  It is recommended by Keegan, Dledrich, & Pelpert (2014) that patients testing positive be 
retested in 3 months to ensure the infection is cleared. 
The strengths of the study by Keegan, Dledrich, & Pelpert (2014) include the review of 
randomized controlled trials and meta-analysis, as well as linking data to recommendations made 
by CDC and the USPSTF.  It considered all major aspects of chlamydia from a primary care 
standpoint as well as highlighting key recommendations to improve screening.  Unfortunately, 
the study does not expand on barriers to screening and the recommendations for financially 
incentivizing providers to enhance screening is not always feasible in areas serving low socio-
economic and minority populations. 
Interventions to increase rates for chlamydia screening in primary care were evaluated by 
Guy et al. (2011) in a systematic review.  In total there were 16 interventions with 15 of them 
targeting females.  Of these 15 interventions for females, 6 were associated with statistically 
significant increases in chlamydia screening rates.  The 6 interventions included 1) a multi-
faceted quality improvement program that included urine collection from all patients at 
registration, 2) linking screening to routine PAP smears, 3) computer notification system for 
doctors, 4) education workshop for clinical staff, 5) internet based continuing medical education, 
and 6) offering free sexual health consultations to patients. The multi-faceted quality 
improvement program included a 4-stage clinical improvement initiative which included 
capacity building, development of a clinic flow-chart, monthly meetings to identify screening 
barriers and strategies to overcome them, development of performance indicators, and a 
universal urine specimen collection from all patients included in the program at the time of 
registration. This quality improvement program demonstrated an improvement in screening rates 
from 21% to 65% with effects that were sustainable for 18 months and shows that a multi-
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faceted approach to improving chlamydia screening rates can be effective.  The second 
intervention included linking chlamydia screening to PAP smears in a randomized controlled 
trial in Australia resulted in a small but significant increase in screening from 4.5% to 6.9%. The 
third intervention included the use of a computer notification for physicians, was based on a 
randomized controlled trial in Australia, and the results demonstrated an increase in chlamydia 
screening from 10.6% to 12.2%.  The fourth intervention was based on an education workshop 
for staff and resulted in a 33% increase in screening rates with effects that lasted for 10 months.  
The fifth intervention was based on continuing medical education for physicians which results in 
an increase in chlamydia screening rates from 12.4% to 15.5%.  The sixth intervention involved 
offering free sexual health consultations to patients in New Zealand and this intervention resulted 
in increased screening rates from 13.2% to 16.8%.  Each of these six interventions demonstrated 
statistically significant improvement to chlamydia screening and can be helpful in identifying 
solutions for increasing chlamydia screening. 
Strengths of the study included the focus on evaluating interventions aimed at improving 
chlamydia screening rates and included a review of high quality RCTs with large patient 
populations (Guy et al., 2011).  Also, cost and complexity of implementation were not exclusion 
criteria, thus many different types of interventions were reviewed. Of note, two of the 
interventions reviewed in this study (computer notification and education workshop for clinical 
staff) are components within this quality improvement project.  Limitations of the study include 
the lack of screening for a specific high-risk population (sexually active females aged 24 and 
younger), the linking of chlamydia screening to PAP smears excludes females under 20 who are 
ineligible for PAP smears.  It was also noted that the development of an interactive workshop for 
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staff education would require significant staff resources and would be challenging to roll out on a 
large scale.  
McDonagh and colleagues (2018) completed a systematic review to identify barriers and 
facilitators to chlamydia testing for young people as well as providers within a primary care 
setting.  Thirty-nine papers met the review’s inclusion criteria with 14 focusing on patients and 
25 focusing on providers.  The Capability, Opportunity, and Motivational model of behavior 
(COM-B) was used to identify the facilitators and barriers for chlamydia screening.  Barriers and 
facilitators were identified at the patient, provider, and service level.  This review helped clarify 
the complexity of chlamydia testing behavior while also providing guidance on how to improve 
chlamydia testing within a primary care setting. 
Barriers to care limit or prevent people from receiving good quality health care.  Several 
barriers to chlamydia screening were identified and broke down by patient, provider, or facility 
by McDonagh and colleagues (2018).  For patients, barriers include a lack of 
education/knowledge/awareness, beliefs regarding risks, embarrassment, fear of receiving a 
positive result, and stigma. For providers, barriers include a lack of training and skills, 
knowledge and awareness, forgetfulness, the perception of patients, the challenge of discussing 
screening, and effects on the doctor/patient relationship.  For facilities, barriers include lack of 
practice nurse involvement, lack of testing guidance, unattainable targets, time-constraint, testing 
based on behavior, costs of testing, and testing policy/cultural norms. 
Facilitators are things that provide support to individuals or groups of people in order to 
achieve beneficial change. McDonagh and colleagues (2018) also identified several facilitators to 
chlamydia screening and broke them out by patient, provider, or facility.  For patients, 
facilitators include increasing knowledge/education/awareness, the belief that testing was 
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responsible/mature/healthy, worries of an asymptomatic infection, and easy availability for 
testing.  For providers, facilitators include skills-based training, increasing 
knowledge/awareness/education, increasing confidence, modes of testing, and the consultation 
context. For facilities, facilitators include involving practice nurses, prompts and reminders, 
reward and incentive programs, feedback on efforts, promotional material, and testing policy. 
McDonagh and colleagues (2018) highlight the complex nature of screening for 
chlamydia within the primary care setting.  Time limitation was identified as a barrier that 
spanned the patient, the provider, as well as the facility. Standard primary care doctor 
appointments can be as short as 15 minutes in length, covering primary complaints, management 
of chronic conditions, and all health maintenance which can severely limit the amount of time 
available to discuss chlamydia screening. Normalization was a component found to be a 
facilitator that also spanned the patient, provider, and facility. Other components were found to 
be both a barrier and facilitator. The involvement of reception staff could improve screening by 
addressing workload and time constraints, but at the same time they are ill-equipped to answer 
questions and patients found the reception area unacceptable for initiating testing.  Themes that 
emerged from the study included the need to normalize testing as universal and to embed it 
within routines, preserve patient privacy regarding sexual history and screening, address time-
constraints, and offer testing in a context that addresses potential stigma.  Other aspects were 
found to be more directly related.  Lack of provider training and knowledge were associated with 
less confidence in conducting screening.  Forgetfulness was related to a lack of a reminder 
system.  Finally, patient’s perceived risk was mediated through awareness and education on 
chlamydia. 
INCREASING CHLAMYDIA SCREENING IN PRIMARY CARE 15 
Strengths of the review by McDonagh and colleagues (2018) include its comprehensive 
analysis of multi-level as well as theoretical barriers and facilitators associated with chlamydia 
screening.  By implementing clinic-based interventions that overcome barriers or leverage 
facilitators, projects designed to improve chlamydia screening stand a much higher chance of 
success.  It is also based on the COM-B model which develops a framework for evaluating and 
explaining chlamydia testing within the primary care setting and can serve as a foundation for 
future interventions.  Limitations of this review include the lack of background, demographics, 
or testing patterns of the providers or facilities, which would have provided context for the input 
of staff. Also, patients in this review may or may not have been offered chlamydia test, and if 
they had, it could have been in any setting.  Therefore, feelings and input at the time of interview 
may not represent what would actually happen if they were offered a test at their primary care 
clinic.  
Wong et al. (2019) conducted a systematic review evaluating interventions used to 
improve chlamydia screening; assessing effectiveness while also evaluating variabilities within 
the interventions which can make it difficult to determine effectiveness.  The socioecological 
model was used to organize interventions, including classifications for individual, interpersonal, 
organizational, community, and policy.  At the level of the individual and interpersonal, results 
demonstrate that providing home-based chlamydia screening tests was an effective solution to 
increase screening but identified its cost-effectiveness as a potential barrier to success and 
requiring further research.  At the organizational level interventions were further broken down 
into low-cost (<$1,000), moderate-cost ($1,000 to $10,000) and high-cost (>$10,000).  Effective 
low-cost interventions included strategic collection cup placement, routine collection during 
consultations, and use of an electronic health record notification.  Moderate-cost interventions 
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that were found to be effective included use of postcards and telephone calls.  High-cost 
interventions found effective were based on dedicated staff screening and offering free sexual 
health consultations.  Challenges for implementing effective solution at the organizational level 
include the lack of protocols for obtaining urine samples, insufficient knowledge about 
chlamydia and urine-based tests, and reluctance of staff to engage in screening adolescents for 
sexually transmitted infections.  At a community level this review found that screening within a 
juvenile detention/correctional facility, or an educational setting is an effective method for 
screening within high prevalence settings.  It found that outreach programs may achieve high 
participation rates but suffer from limited reach, and that the most effective solutions are mostly 
not publicly available.  At the policy level this review identified that providing education, either 
through an educational package, a health advisor to increase awareness and train staff, or an 
internet-based medical education program, was an effective method of increasing chlamydia 
screening while noting that for a variety of reasons many clinicians are hesitant to screen 
sexually active asymptomatic female patients.   
CSIP was able to leverage research from the Wong et al. (2019) review demonstrating 
that use of an electronic health record notification system is an effective and cost-efficient 
solution for increasing rates of chlamydia screening.  Recommendations for an educational 
package for practitioners and the use of internet-based education can help to improve knowledge 
and confidence regarding chlamydia were incorporated into the project and may also serve to 
address concerns brought up in the review identifying insufficient knowledge about chlamydia 
for the individual patient as knowledgeable staff members may be able to field questions and 
educate patients.  Future research would benefit from further evaluating home testing kits in 
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order to determine when cost becomes effective and to further evaluate the impact use of a 
home-testing kit can have on chlamydia screening rates.   
McNulty et al. (2013) conducted a prospective cluster randomized control trial to 
evaluate if a structured complex intervention increased chlamydia screening rates in a primary 
care setting.  Randomizing can be difficult to conceal when evaluating an educational 
component, thus a modified Zelen design was used and overcomes this concern by not informing 
any participants they are in a trial.  The multifaceted complex intervention is based on a 
cognitive theory such as the theory of Planned Behavior which has been demonstrated as 
effective to help change behavior.  This RCT targeted patients aged 15 to 24 years old and 
involved 160 primary care offices: with 80 in the intervention group and 80 in the control group.   
The intervention was broken down into different components to address aspects of the 
theory of planned behavior such as changing personal attitudes, subjective norms, and behavior 
controls.  In the area of changing personal attitudes, interventions included a workshop showing 
how common chlamydia is and the benefits of testing asymptomatic populations, develop testing 
targets, provide feedback/champions/screening performance through monthly newsletters, 
providing a certificate of training as well as a certificate of personal development.  In 
establishing subjective norms interventions included an invitation for all staff to participate in the 
workshop, providing posters for the clinic that state “WE are a chlamydia screening practice”, 
facilitating teamwork through inclusion of chlamydia testing as a standing agenda in practice 
meetings, the publishing of a monthly newsletter providing information on screening rates, and 
adding a pop-up reminder for targeted population in order to normalize the offer.  In the area of 
behavioral controls, interventions included a workshop with protected learning time to improve 
staff knowledge and inspire self-confidence to offer screening, registration to provide invitation 
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cards for patients to ask for screening, adding chlamydia screening to order templates for 
different consultations such as (i.e. contraception/asthma/travel/etc), and to offer a web-based 
education module to allow those who cannot make the workshop to still undertake training and 
receive a certificate.  The use of this complex intervention led to an overall 76% increase in 
chlamydia screening across all practices who received the intervention as compared to those that 
did not use the intervention.  Absolute testing rates for 15- to 24-year-old patients increased from 
2.43 to 4.34 per 100 patients in the intervention group compared with controls that increased 
from 2.61 to 3.00 per 100 patients, unadjusted ratio 1.66 (CI 1.1 to 2.5).  In the 34 practices that 
utilized electronic notifications as part of their intervention results demonstrated the testing rate 
was 2.81 times as great as in the control group (RR 2.81, 95% CI 1.91 to 4.13, p<0.001). 
Results from the RCT by McNulty et al. (2013) support the idea that CSIP can see 
improvement in screening rates through use of education and electronic notification.  A strength 
of the study was that it was a randomized control trial, which evaluated and demonstrated a 
significant improvement in screening rates through use of electronic notification system.  In 
evaluating this data for use in CSIP, a weakness in the trial was that the education was integrated 
into the complex intervention in such a way that it became challenging to extract the degree to 
which the education component affected screening rates as compared to, for example, the posters 
that state “WE are a chlamydia screening practice”.  As the only aspect of the intervention 
reporting detailed data was the electronic notification, moving forward it would be beneficial to 
parse out how much of an impact each portion of the complex intervention had on the outcome 
measure. 
Karas et al. (2018) conducted a retrospective review evaluating the impact of pop-up 
alerts and education on chlamydia screening rates in female patients aged 13 to 21 years old who 
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are presenting for preventative care.  The review was conducted across a large network of 27 
pediatric primary care offices that serve urban, suburban, and rural areas within the US.  The 
intervention was based on a clinical decision support (CDS) which is considered to be a process 
of enhancing health-related decisions and actions with pertinent, organized clinical knowledge 
and patient information to improve both health and healthcare delivery.  This is part of the CDS 
5 Rights framework which asserts that interventions must provide the right information, to the 
right people, via the right channels, in the right format, and at the right point in the workflow.  
The primary goal of the intervention was to increase chlamydia screening rates in sexually active 
high-risk females.  Secondary goals included increasing provider awareness of screening 
guidelines, incorporating CDS with appropriate treatment, and provide recommendations for 
follow-up. 
The intervention was incorporated in the EPIC electronic medical record system.  When 
the patient chart was opened in EPIC it would scan the patient’s health record for any indication 
of sexual activity, including sexually-related diagnosis in the problem list, indication of sexually 
activity in the social history, or mention of sexual activity in the history of presenting illness.  
EPIC would then scan for a screening order within the prior year and if it did not exist EPIC 
would activate an alert that the patient was a candidate from screening.  The provider then had 
the option to open an order set that contained appropriate screening labs and billing diagnosis.  In 
conjunction with the pop-up, this intervention also provided an educational component which 
included 2 presentations by an adolescent medicine specialist and a quarterly newsletter 
distributed to the medical offices for 2 years.  Rates for screening in the year prior the 
intervention were at 2.4% and increased to 5.01% in the year after the intervention (p<0.01).   
Overall, the proportion of screened patients before and after the intervention was statistically 
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different (OR=2.143, 95% CI 1.833 to 2.504), which means the odds of a sexually active female 
being screened after the intervention was 2.143 times higher than before the intervention.  
This review and intervention are very similar in structure to CSIP and the results support 
the likelihood of success with CSIP.  A strength of the review is that the pop-up notification 
provided an easy link to opening an order set which conveniently provides the correct screening 
test as well as adjunct order (i.e., retest in 3 months) for the provider to acknowledge.  This saves 
additional time, increases convenience, and decreases the chances of an incorrect or missed 
screening order.  CSIP did not include this and future QI project would benefit from including 
this and evaluating how it impacts screening rates.  Also, the use of a quarterly newsletter 
improves awareness of chlamydia screening for providers within the office but it’s effects might 
be best utilized in a setting with multiple offices.  The use of an adolescent specialist to provide 
education could be seen as a strength but in the setting of Covid, where remote access education 
was necessary, the benefit of using a specialist capable of answering questions and giving more 
in-depth information and richer context was not possible. 
Ursa, Greenberg, & McKee (2019) conducted a case study looking at the use of Plan-Do-
Check-Adjust (PDCA) as a framework for quality improvement to improve chlamydia screening 
in women aged 16 to 24 years old.  The use of chlamydia screening was used because of the 
health burden that the infection poses, the availability of non-invasive screening tests, success of 
treatment and the institution’s low rates screening which needed improvement.  The project was 
a multidisciplinary collaboration (i.e., family medicine, internal medicine, pediatrics, obstetrics 
and gynecology, and the University Health Service) within the University of Michigan Health 
System, which is an academic institution in the Midwest United States over a 1-year period.  The 
intervention included a workflow review, educational material, and clinical decision support tool 
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that was integrated into the Electronic Medical Record (EMR) system.  Data collection included 
outputs from the EMR as well as interviews with clinicians and staff to understand the current 
state and challenges of chlamydia screening.  The PDCA process for workflow review involves 
nine-steps which include 1) Assemble the team, 2) Identify the problem, 3) Prepare, 4) Set a 
goal, 5) Identify barriers, 6) Develop a solution, 7) Pilot, 8) Large scale rollout, and 9) Assess 
and modify.  The educational material was created for staff, patients, and parents and explained 
the importance of screening, the process of screening, and how notifications of results and 
treatment works.  The clinical decision support tool consisted of an alert that displayed in an area 
of the EMR called “best practice advisories”.  Screening rates for this population was at 29% and 
results of this QI project demonstrated that after 1-year rates of screening had increased to 60%.  
This project incorporated electronic notifications through the use EPIC and notifications 
were placed in an area called “best practice advisories”, which is the same EMR and 
implementation method used in CSIP, with similar outcomes.  A weakness of this case study was 
the lack of detailed information on the educational component.  Research has demonstrated that 
education is effective raising awareness, increasing knowledge, and inspiring confidence.  Thus, 
it is likely that the educational component of this intervention was instrumental in the results 
demonstrated.  Future studies would benefit from a more detailed review of the education in 
order to see how details of setting, content and delivery can affect project outcomes.   
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PICOT Question 
 For sexually active females aged 24 and younger, does use of an electronic notification 
system with targeted education improve screening rates for chlamydia, as opposed to the 
standard care model, over a one-year period. 
Rationale / Framework 
Despite strong recommendations from several professional organizations, advances in 
readily available knowledge (i.e. internet) for the general public, as well as government funding 
to cover the costs of screening and treatment for those in underserved and low socio-economic 
communities, overall rates for chlamydia screening remains low.  Research demonstrates there 
are important gaps in patient knowledge, self-reported practices in primary care providers, time 
constraints, and the lack of a formal reminder system may contribute to low chlamydia testing 
rates and suboptimal management of infection (Lorch et al., 2013).  By implementing CSIP, that 
leverages technological advances in combination with education supported by Kotter’s change 
management model, identified gaps can be filled to improve the health and wellness of a 
population that represents the next generation of mothers.  Sexually active adolescent females 
living in underserved and low socio-economic communities have unique and multi-faced 
challenges with maintaining health and wellness.  Members of this target population are typically 
unaware of the possibility or risk of an asymptomatic infection.  This lack of awareness can lead 
to lifelong sequalae and place a large burden on the healthcare system and society in general.  
The goal with CSIP is to improve chlamydia screening within an underserved population, 
resulting in increased health and wellness within the community. 
Managers in today’s healthcare system are in an extremely challenging position as they 
strive to maintain a competitive edge while leading the organization through constant change.  
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Kotter’s change management model can be utilized for this project and is based on a dynamic, 
non-linear 8-step approach to implementing change.  This model includes 1) increasing urgency, 
2) build guiding teams, 3) get the vision right, 4) communicate for buy-in, 5) enable action, 6) 
create short-term wins, 7) don’t let up, and 8) make it stick.  This is not a step-by-step method for 
managing change but, instead is an iterative model that relies on the skills and knowledge of the 
manager who is bringing about change.  For example, the manager may create a series of short-
term wins in order to build guiding teams.  During periods of change managers must deal with 
staff emotions that can work to undermine attempts at promoting change.  Kotter’s model 
provides tools to turn negative feelings into positive proactive feelings such as faith, trust, 
optimism, urgency, reality-based pride, passion, excitement, hope, and enthusiasm – which are 
emotions that promote change (Campbell, 2020).  Kotter’s change management model is being 
used to address anticipated team resistance to change and to support implementation of this 
project. 
AIM Statement 
The Chlamydia Screening Improvement Project (CSIP) aims to increase the 
chlamydia screening rate at a federally qualified healthcare center in California, from a 
baseline of 14% to 60% in sexually active females aged 24 and younger over a 12-month 
period.  CSIP will utilize an electronic notification system within the EMR, aim to 
increase staff awareness, provide staff education to increase confidence, and develop a 
feedback system to facilitate improvement. 
Context 
A needs assessment was completed at a federally qualified healthcare center (FQHC) in 
California hosting 12 providers and evaluated chlamydia screening rates for the high-risk 
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populations of females aged 13 to 24 years old.  For the year 2019 screening rates for chlamydia 
were found to be 14%.  Stakeholders were contacted and verbalized readiness in supporting 
practice change.  This project leveraged research that shows a multi-faceted approach may be 
effective, including medical alerts reminding providers, targeted education for the providers, as 
well as medical assistants to help overcome barriers related to provider lack of time and capacity 
(Kong et al., 2011).  Previously, the FQHC site functioned with an older electronic medical 
record system (CernerÒ) but, this older system did not include provisions for notification or 
reminders.  The electronic medical record system changed to EPICÒ in May 2019 and provision 
were included that allowed for configurable notification reminders.   
Major stakeholders in this project included the patient, care provider, medical 
assistant, and management team within the FQHC.  Patients have a pivotal role within the 
project as their care is being affected and enhanced through implementation of the 
project.  The FQHC serves an area of California with one of the lowest public safety 
opportunity indexes, lowest life expectancies, and a higher-than-average percentage of 
low socio-economic and minority population (Haley, Zimmerman, Woolf, & Evans, 
2012).  High risk patients who are unaware of an asymptomatic infection can be 
identified and treated resulting in improved health and wellness.  Care providers include 
the medical doctors as well as nurse practitioners, and they are responsible for managing 
primary care to the patient population.  CSIP affects them directly as they received the 
intervention of the project, and subsequently provide the necessary orders to screen this 
patient population.  Medical assistants are front line workers in this FQHC site and are 
involved with the many aspects of patient care.  As it relates to this project, they provided 
the chlamydia testing kit to the patient as well as education on how to prepare and 
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provide the test sample.  The management team at this FQHC is responsible for 
developing and maintaining policies within the organization. In addition, they also drive 
expectations, meet company goals, maintain financial responsibility, and improving 
operations within the organization.  CSIP stands to impact the management team by 
improving screening benchmarks, financial reimbursement, and performance metrics 
within the organization. 
Proposed Intervention 
 CSIP is a multi-faceted quality improvement protocol targeting the screening of sexually 
active females aged 24 years old and younger within the primary care setting of an FQHC in 
California.  The project includes education, inclusion of an electronic notification system, and 
establishment of appropriate follow-up. 
 Education is vital to the success of the project and supports facilitating change within the 
organization.  The educational component of this protocol included a PowerPoint presentation 
that disseminated relevant information to key stakeholders of the healthcare team, including 
current screening rates, prevalence of asymptomatic infection, risks of untreated infection, nature 
of the planned intervention, testing methods, project goals, and important information to be 
shared with patients.  Key stakeholders receiving the education would include the management 
team, treating providers, and medical assistants.  Opportunities were planned during education to 
illicit questions, concerns, and feedback on the information and project plan.  Additionally, the 
education component of the project was planned to be recorded and made available as a video to 
all employees to view.  By doing this we intended to help ensure all stakeholders were privy to 
the education component regardless of location, schedule, or availability.  The education 
component was intended to not only educate, but also to engage and establish urgency with key 
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stakeholders of the healthcare team.  The educational component helps increase the likelihood of 
successful project implementation by way of key stakeholder participation and buy-in.     
 The inclusion of an electronic notification system was the functional change driving the 
project.  By adding an electronic notification system, busy care providers were reminded that 
chlamydia screening is recommended for this patient, and it occurs upon opening the patient’s 
electronic medical record.  This allowed providers to minimize distractions regarding 
comprehensive care and focus on chief complaint.  A benefit of this notification system was that, 
in addition to notifying the primary provider, it also notified care team members such as medical 
assistants.  This facilitates team-based care, allows medical assistants to proactively obtain 
specimens and provides the possibility of having medical assistants place chlamydia screening 
orders per protocol.   
The electronic medical record system at this FQHC transitioned from CernerÒ to EPICÒ 
and the functionality was activated as part of the transition to the EPICÒ platform.  In its 
primary implementation the notification was listed on the front page of the patient chart as a 
hyperlink entitled “Healthcare Maintenance”.  This link appears in the chart when healthcare 
maintenance is due on the patient.  By clicking on the link providers are taken to a page where a 
comprehensive list of applicable healthcare maintenance is provided.  When no healthcare 
maintenance is due the hyperlink is not provided.  Examples of other comprehensive healthcare 
maintenance that may be listed include alcohol abuse screening, breast cancer screening, cervical 
cancer screening, cholesterol screening, diabetes screening, depression screening, influenza 
vaccine, pneumococcal vaccine, TDAP vaccine, varicella zoster vaccine, and many more. 
 Establishing appropriate follow-up is an important component for effective chlamydia 
screening and treatment.  Provided that screening results are negative, a telephone-based or email 
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notification would be appropriate. Care must be taken to avoid leaving voice messages with 
medical information (including test results) as this might violate HIPAA, thus voicemails should 
have a standardized message asking for a return call.  In the case that screening identifies a 
positive test result (presence of infection), a follow-up appointment should be made with a tele-
health appoint being a viable option.  This appointment serves to notify the patient of the positive 
test results, educate on pathology of disease as well as treatment, ordering of appropriate 
treatment for the patient as well as sexual partner, and scheduling a follow up appointment in 
three months to ensure reinfection does not occur. 
 We established that all female patients aged 24 and younger have annual reminders 
provided to the primary care providers for chlamydia screening.  Thus, the proposed intervention 
is an electronic notification reminder within the electronic medical record system.  The current 
standard is no electronic reminder, where providers are tasked with manually looking up if 
patients in this targeted population are due for screening. 
SWOT Analysis 
At the time of the needs assessment the primary care clinic was transitioning electronic 
medical record systems, from CernerÒ to EPICÒ.  As such, one of the strengths of this project is 
that it was very easy to implement and required only management buy-in for the electronic 
notification system to be an activated feature on roll-out.  The leveraging and use of enhanced 
technology to improve efficiencies of care within a primary care setting is also a strength of this 
project.  Finally, the staff at this clinical site has a good amount of experience, with low attrition 
rate, and this consistency and established teamwork will strengthen the success of this project. 
Weaknesses in the project include the need for additional time within a busy primary care 
setting where appointments are normally 15 minutes in length and great efforts already exist to 
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avoid running behind on appointment schedules.  Corporate policies within a primary care clinic 
setting can help to establish standards of care and prevent harm but also serve to limit 
adaptability within a quickly changing environment and can potentially weaken the long-term 
impact of this project.  There are many different types of screening for different populations 
within a primary care setting, and transitioning to a new notification system will activate all 
notifications, thus providers will initially be inundated with potentially multiple screening 
notifications for each patient.  This can result in notification fatigue which may increase the 
chances providers will initially ignore notifications and this will serve to weaken the project. 
Opportunities refer to external influences that can benefit, or be benefitted by the project.  
An area of opportunity with this project is the increasing education and dissemination of 
knowledge regarding chlamydia screening, testing, and treatment.  As the site of the project is a 
multi-center non-profit organization there is the opportunity for business development through 
increased reimbursement by expanding the project throughout the organization.  There is also the 
opportunity for business development as the components of the project bundle can be readily 
adapted to improve other screening needs.  Examples of this might include depression, smoking, 
obesity, HIV, etc.   
Threats to the project can come from social and cultural influences in the community, as 
patients may see chlamydia screening at taboo, be uncertain how to talk about it with family or 
partners, and may choose to avoid the matter all-together.  The political and economic landscape 
includes former President Trump policy and funding changes to reduce healthcare coverage for 
underserved populations which threatens the sustainability of the project.  The current healthcare 
focus is on the Covid-19 pandemic which has resulted in the increase of tele-health visits with a 
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decreased number of in-clinic appointments, which threatens the impact of this project.   A 
summary and graphic representation of the SWOT analysis can be found in Appendix B. 
Cost Benefit Analysis and Return on Investment (ROI) 
 The Centers for Disease Control and Prevention state the direct medical cost for 
chlamydia, including diagnosis and treating chlamydia-associated infertility, are estimated at 
$701 million annually (CDC, 2011).  Given that the majority of infections are asymptomatic, 
establishing a cost benefit analysis relies on a combination of data and estimates, and data on the 
topic is limited.  First, not every case of chlamydia infection will result in comorbidity.  
According to Herzog et al., (2012) the estimated fraction of chlamydia infected women that 
develop into pelvic inflammatory disease is 10% (95% CI, 7-13%).  Second, a value needs to be 
associated with each case of PID.  Based on research by Chesson, Collins, & Koski, (2008) the 
average medical costs of each case of PID were $1,995, which included the costs of care for 
acute PID and costs associated with sequelae such as chronic pelvic pain, ectopic pregnancy, and 
infertility.  Finally, data is required on the incidence of chlamydia within the United States.  
According to the Centers for Disease Control and Prevention, in 2018 there 1,758,668 reported 
cases of chlamydia in the U.S. but an estimated 2.86 million infections occur annually (CDC, 
2016).  Assuming females account for 50% of the population there would be 1.43 million 
infections that occur annually in females.  With PID occurring in 10% of these 1.43 million 
annual infections, the incidence of PID resulting from chlamydia results in 143,000 cases 
annually.  As the cost of each case of PID is estimated at $1,995, and the incidence is 143,000, 
the net cost of failing to screen for chlamydia is estimated to be in excess of $285 million dollars 
annually.  
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 The Fruitvale neighborhood of Oakland California lies within Alameda County and has 
total population of 50,294 (Wikipedia, 2021).  Assuming 50% of the population is female it can 
be estimated that approximately 25,147 females live within the community surrounding Native 
American Health Center.  According to Healthy Alameda County website, a source of population 
data and community health information provided by the Alameda County Public Health 
Department, the prevalence of chlamydia within the county is 584.5 per 100,000 people (2019).  
Therefore, an estimated 147 cases of chlamydia occur annually in females living within the 
community surrounding NAHC.  As PID occurs in 10% of these 147 cases, and a cost of $1,995 
per case to treat, an estimated total cost of treating PID in this community can be calculated as 
$29,326.50 per year (Appendix I). 
 There are no direct financial up-front costs associated with CSIP.  Secondary costs 
include the cost of time for developing educational material, surveys, project oversight, and 
compensating staff for completing education and survey time.  At a rate of $60 per hour (typical 
clinic physician rate) and an estimated time of 16 hours for development, secondary costs are 
estimated to be $960.  Estimating six physicians at $60 per hour and six medical assistants at $30 
per hour, and a total of 30 minutes for education and survey, the total lost costs in time are 
estimated to be $5,400.  Thus, total project costs are estimated to be $6,360.   
GANTT Chart Narrative 
A GANTT chart (Appendix E) was used to outline the workflow and milestones for 
CSIP.  The total project length was 18 months from the initial need’s assessment, illustrated in 
the GANTT chart, and began upon approval of the stakeholders. Pre-intervention data was pulled 
from the prior 12-month period and referenced while research is conducted and the electronic 
notification component of the project is implemented.  After a 12-month period data was pulled 
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again and reviewed to assess the impact of the electronic notification.  A pre-education survey 
was developed and distributed to assess a baseline level of knowledge and confidence by clinic 
staff.  The educational component of CSIP was then developed and provided to all staff 
members.  The process of development, distribution, and completion of the education component 
took approximately 4 months.  A post-education survey was then distributed to assess the post-
education level of knowledge and confidence by clinic staff.  Once the survey was completed, 
data was pulled again and reviewed to assess the impact of the electronic notification in 
combination with the educational piece of the project.  Finally, a post-project debriefing was 
conducted to review results of the data, assess the impact of the project on overall screening 
rates, and provide an opportunity for feedback, evaluation, and improvements.   
Outcome Measures 
The primary outcome for this project is an increase in chlamydia screening rates for 
sexually active females aged 24 years old and younger from 14% to 60%.  Baseline data was 
from the previous EMR that included a review of the targeted patients by age seen over the time 
period from May 2018 through May 2019, and compared to the total number of orders for 
chlamydia screening over the same time period.  After implementing the interventions, screening 
rate data was analyzed through the EPICÒ EMR system over a one-year period, from May 2019 
through May 2020.  Data reflecting screening rates to identify how the use of reminders built 
within the electronic medical record system affected screening rates. 
Secondary outcomes were measured include provider increase in knowledge, comfort, 
and ease of enacting chlamydia screening.  A general review of the process including workflow 
and response was analyzed.  Lastly, identification of possible barriers to increasing screening 
rates was reviewed through this intervention. 
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Analysis Methods 
 Analyzing the effects of this project on screening rates for chlamydia consisted of a 
comprehensive review that included 1) assessing care team understanding and knowledge of 
chlamydia, 2) evaluating providers response to the protocol, 3) evaluating rates of testing, 4) 
evaluating the identification of infection caught through screening, 5) and performing a 
secondary analysis of why patients did not complete testing.  
 A pre and post knowledge survey was used to assess the care team’s knowledge and 
comfort level surrounding chlamydia screening.  Post project provider satisfaction with the 
workflow and intervention was assessed to distinguish any issues.  The care team included 
medical assistants (MA’s) who served to provide initial contact with the patient, provide 
specimen collection kits to patients, facilitate initial questions regarding screening, and provide 
discharge instructions which include ensuring all questions have been answered.  The survey was 
provided to assess knowledge and comfort pre and post intervention, and served as valuable 
information for assessing the educational component of the protocol. 
 A survey was also used to assess providers satisfaction with implementation of the 
project protocol.  Primary care providers are responsible for ordering screening tests, making the 
recommendation for screening, addressing patient concerns surrounding screening, educating on 
the details of infection as well as answering all patient questions.  The CSIP addressed gaps in 
knowledge as well as inspired confidence with initiating conversation and enable the 
recommended screening for high-risk patients.  Results from this survey were used to assess the 
impact of the educational component of this protocol.  In addition, it provided subjective input as 
to the implementation of the electronic notification used within the protocol.   
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 Data reports were available via software that were generated from the two electronic 
medical record systems used, one pre and one post intervention, that identified patients being 
screen for chlamydia.  These data included filters for female patients, aged 13 to 24 years, with 
chlamydia testing performed as either urine, vaginal, or cervical, being performed over the one-
year periods specified, including any provider, and occurring at the clinic location.  The search 
criteria identified the targeted population, established the total population, determined if each 
patient had an annual chlamydia screening performed, and a percentage of the total target 
population who had screening completed could be calculated. 
 Reports were also available via software than be generated from the two electronic 
medical record systems used, one pre and one post intervention, that identified patients who were 
found to have a chlamydia infection.  These reports included filters for female patients, aged 13 
to 24 years, with chlamydia testing performed as either urine, vaginal, or cervical, being 
performed over the one-year periods specified, who were positive for chlamydia, including any 
provider, and occurring within the clinic site.  The search criteria identified the targeted 
population, established the total population of those screened, determined which patient had a 
positive chlamydia test result, and a percentage of the total target population who had positive 
test results was calculated. 
   
Ethical Considerations 
This project is designed to enhance screening rates for chlamydia and this touches on 
several ethical topics which will be considered here.  Such topics include autonomy, beneficence, 
justice, non-maleficence, and veracity (American Nurses Association, 2015).   
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Autonomy revolves around maintaining the patient's right to choose what medical care is 
provided to them.  For chlamydia screening it’s important to recognize that the patient has the 
right to choose to not be screened, and while this possibility is in-fact a limitation within this 
project, it’s vital to recognize and support the patient’s choice as to what happens to them from a 
preventative healthcare standpoint.   
Beneficence refers to the act of providing a benefit or doing good for the patient.  The 
ethical consideration of beneficence is the basis for this project as improved screening rates can 
lower infection rates, reduce comorbidities, and benefit the overall health and wellness of the 
community.   
In its broadest sense Justice refers to the idea of people getting what they deserve, and 
when considered through the lens of morality may also be seen as “what we owe each other”.  
Distributive justice is a subset of justice that applies to distributing goods or services of various 
kinds to individuals.  Improving screening rates for chlamydia is not only a “just” act in that we 
owe the opportunity for health and wellness to each other but, this project also enhances 
distributive justice in ensuring that screening opportunities are distributed to underserved and 
minority populations.   
Non-maleficence is the ethical principle that ensures that we “do no harm” to others.  
When considering non-maleficence, we have to evaluate the risks involved with screening 
patients for chlamydia.  In addition to the risks of physical harm, we also address the risks of 
psychological, social, and emotional harm.  Screening for chlamydia does pose risks for 
emotional distress stemming from the fear, anxiety, and embarrassment of testing and the 
possibility of being infected.  There is also the risk of social harm, despite great strides in 
protecting patient privacy, that the patient may share details of testing with family or friends and 
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how they may be viewed by their support system.  It’s important to highlight that this patient 
population includes adolescents and this stage of development emphasizes the acceptance of 
family and friends.     
Veracity is the ethical principle that addresses honesty and truthfulness in 
communication.  Within that healthcare setting, and as it relates to this project, veracity is the 
comprehensive, accurate, and objective sharing of information as well as ensuring the patient’s 
understanding of that information.  As it relates to screening for chlamydia, the consideration of 
veracity translates to ensuring that this patient population is informed of recommendation for 
screening, made aware of the risks and benefits, and have all questions answered honestly and 
based on current evidence. 
The University of San Francisco Jesuit values are reflected within CSIP.  These values 
include Cura Personalis (care for the whole person), being people for others, and diversity in all 
its forms (University of San Francisco, 2021).  By striving to identify and prevent disease, we 
serve to care for the physical person while simultaneously caring for the whole person through 
commitment to autonomy and respect for individual values.  This project has helped to 
demonstrate a calling to consider, help, and provide a service to everyone.  Furthermore, by 
implementing this project in an underserved area of California, within an FQHC organization, 
and by providing care to all who need it, we are working to serve the diversity of the community.  
Patient confidentiality was honored, participants screening data was anonymous, and all 
aspects of HIPPA was monitored throughout the CSIP.  Both Cerner and EPIC are HIPPA 
compliant EMR systems and data collected on screening rates did not include patient 
identification information.  All human subject research projects require Institutional Review 
Board (IRB) review, regardless of funding.  The CSIP involved only analysis of data or 
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specimens and is not a research project, but instead a quality improvement project.  The intent of 
CSIP is to identify and control a problem, or improve a program/service.  CSIP is to the benefit 
of the participant and participants community, the data that was collected was used to assess and 
improve a problem/program/service, the knowledge collected is not generalized beyond the 
scope of the activity, and there were no experimental activities conducted, thus CSIP does not 
constitute a research project and IRB review was not required. 
Results 
 A total of 312 high-risk patients were identified for screening between 6/17/19 and 
6/17/20 (referred to as 2020), following the implementation of this project.  A review of the same 
patient population for year prior, between 6/17/18 and 6/17/19 (referred to as 2019), revealed a 
total of 285 patients.  This translates to a 9.4% increase in the total population of high-risk 
individuals for chlamydia infection, for this location between 2019 and 2020.  The number of 
people screened for chlamydia in 2019 was 40 out of 285 total patients and equals a 14% 
screening rate.  For 2020, the year 
following the implementation of 
CSIP, the number of people screened 
for chlamydia increased to 156 out of 
312 total patients and equals a 50% 
screening rate (Figure 1).  This 
translates to a 256% increase over the 
prior year.  The Pre-Intervention 
survey was sent out through email on 9/7/2020 and a total of 12 participants completed it.  The 
educational intervention was provided as a PowerPoint Presentation and sent through email to 
 














Total Screened Total Patients
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staff on 9/23/2020.  A total of 6 participants completed the post-Intervention survey which was 
provided on 9/30/2020.  There were 7 questions in the survey, a Likert scale was used to quantify 
data, the value of 1 representing a strong positive response and 5 representing a strong negative 
response (Appendix J). Thus, data with a mean value closer to 1 equates to more confidence and 
knowledge in the area, while a mean value closer to 5 reflects low confidence and knowledge.  
The Standard Deviation refers to the variability of the distribution of data.  Thus, a Standard 
Deviation closer to 0 indicates everyone answered very similarly, while a higher standard 
deviation indicates participants had great variability in their answers.  The same questions were 
used for both the pre- and post-analysis.   
Table 1 – Education Pre- and Post- Survey Data 
Survey Questions Pre-Survey Data Post-Survey Data 




I am comfortable discussing 
chlamydia with a patient 
1.50 0.50 1.50 0.50 
I know what the most common 
symptoms of chlamydia are 
1.83 0.90 1.50 0.50 
I can identify the high-risk population 
for chlamydia infection 
2.17 0.99 2.00 1.41 
I am aware of who should be screened 
for chlamydia regularly 
1.67 1.11 2.00 1.41 
I understand how to test for chlamydia 
 
1.42 1.11 1.33 0.47 
I know how to treat chlamydia 
infection 
1.83 1.14 1.33 0.47 
I understand how to address sexual 
partners and testing for cure 
1.92 0.95 1.83 0.69 
  
Results of survey data are summarized in Table 1 and reveal that prior to the education 
module staff members were on average most comfortable with the topics of how to test for 
chlamydia (mean=1.42) followed by being comfortable discussing chlamydia with a patient 
(mean=1.50).  After the education module was completed, survey data shows that providers 
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remained most comfortable with the topic of how to test for chlamydia (mean=1.33), but now 
also includes how to treat chlamydia infection (mean=1.33).  The pre-survey questions with the 
least confidence included identifying high risk populations (mean=2.17) followed by addressing 
sexual partners and testing for cure (mean=1.92).  After the education module was completed 
survey data revealed that staff members continued to be least comfortable with the questions of 
identifying high-risk population for chlamydia screening (mean=2.00), in addition to identifying 
who should be screened regularly (mean=2.00). 
The education module was created using a PowerPoint format and was developed to 
share current knowledge as well as reinforce understanding of the different aspects of chlamydia 
care, including symptoms, screening, and treatment modalities.  Objectives for the module 
included that by the end of the module participants would be able to describe what chlamydia 
infection is, explain typical symptoms, identify high-risk populations, describe guidelines for 
screening/testing, understand current methods for screening, explain how treatment is provided, 
and identify special considerations of care.  Information was provided from the Centers for 
Disease Control and Prevention as well as several evidence-based research articles, with one 
slide dedicated for expanding on each of the objectives.  The intent of the information was to be 
clear and concise, and contained 11 slides in total.  As a result of Covid-19 and the shelter-in-
place order, the intended plan for in-person education had to be modified to a remote learning 
format.  The education content was converted to an Adobe PDF file to facilitate ease of web 
browser viewing, and provided to the organization.  The organization emailed all providers and 
when providing the email introduced the project, providing the pre-survey link, the education 
component as an attachment, and the post-survey link. 
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  The survey questions were designed to elicit understanding and confidence levels for 
each of the areas of the education module.  Questions are unchanged between the pre- and post-
survey in order to directly compare the effects of the education intervention on the providers.  
Each question is reviewed in greater detail and the results are interpreted for impact and 
effectiveness.  
Question 1 – I am comfortable discussing chlamydia with a patient. 
The first question gauges general overall comfort level for providers while discussing the 
topic of chlamydia with patients.   
Survey Questions Pre-Survey Data Post-Survey Data 




I am comfortable discussing 
chlamydia with a patient 
1.50 0.50 1.50 0.50 
 
The mean score was 1.5 for the pre-survey with 6 providers (50%) stating they felt “very 
comfortable” discussing chlamydia with patients and 6 providers (50%) stating they felt 
“somewhat comfortable”.  The post-survey mean score was also 1.5, with 3 providers (50%) 
stating they felt “very comfortable” discussing chlamydia with patients and 3 providers (50%) 
stating they felt “somewhat comfortable”.  The standard deviation of 0.50 for both pre- and post-
survey demonstrate low variability and high consistency in the answers.  The information from 
this survey questions suggests that providers are comfortable with talking about the subject of 
chlamydia with their patients, and that the education module had no impact on the provider’s 
level of comfort.    
Question 2 – I know what the most common symptoms of chlamydia are. 
The second question queries knowledge regarding what the most common symptoms of 
chlamydia a patient would experience.  Research indicates that most chlamydia infections have 
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no symptoms, and for those that do have symptoms the most common symptoms are vaginal 
discharge and a burning sensation when urinating. 
Survey Questions Pre-Survey Data Post-Survey Data 




I know what the most common 
symptoms of chlamydia are 
1.83 0.90 1.50 0.50 
 
The second question asks about how well they know the most common symptoms of 
chlamydia.  The mean score was 1.83 on the pre-survey with 5 providers (41.67%) stating they 
“strongly agree”, 5 providers (41.67%) stating they “somewhat agree”, 1 provider (8.33%) 
stating “neither agree or disagree” and 1 provider (8.33%) stating “somewhat disagree”.  The 
mean score was 1.50 on the post-survey with 3 providers (50%) stating they “strongly agree” and 
3 providers (50%) stating they “somewhat agree”.  The standard deviation of 0.90 in the pre-
survey, lowering to 0.50 in the post-survey suggests that there was a higher variability in 
knowledge levels but the education module resulted in knowledge of common symptoms 
becoming much more consistent.  This survey data suggests that the education module helped to 
improve understanding of common symptoms of chlamydia.  However, it’s also possible that the 
2 participants who provided low confidence in the pre-survey may not have completed the post-
survey.  
Question 3 – I can identify the high-risk population for chlamydia infection. 
The third question asks how well the provider can identify high-risk populations for 
chlamydia infection.  Research shows that the most high-risk populations for chlamydia infection 
are sexually active females aged 13 to 24 years old.  
 
Survey Questions Pre-Survey Data Post-Survey Data 
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I can identify the high-risk 
population for chlamydia 
infection 
2.17 0.99 2.00 1.41 
 
The mean score was 2.17 on the pre-survey with 2 providers (16.67%) who “strongly 
agree”, 8 providers (66.67%) who “somewhat agree”, 1 provider (8.33%) who “neither agree or 
disagree”, and 1 provider (8.33%) who “strongly disagree”.  The mean score was 2.00 on post-
survey with 3 providers (50%) who “strongly agree”, 2 providers (33.33%) who “somewhat 
agree”, and 1 provider (16.67%) who “strongly disagree”.   The standard deviation of 0.99 on 
pre-survey, increasing to 1.41 on post-survey indicates that participant answers became less 
consistent after the education.  Survey data suggests that providers are not as comfortable with 
identifying high-risk populations for chlamydia as they are with discussing chlamydia.  As the 
number of providers who “strongly agree” rose in the post-survey, from 2 to 3, it further suggests 
that there was improvement in knowledge from the education.  However, the same number of 
providers who “strongly disagree” continued to strongly disagree after the education module.  
This may suggest that providers had questions about the information, did not understand the 
information, or did not agree with the information.   
Question 4 – I am aware of who should be screened for chlamydia regularly. 
The fourth question asks how well providers know who should be screened for chlamydia 
on a regular basis. Research demonstrates that the high-risk population is the group who should 
be screened regularly for chlamydia.  
Survey Questions Pre-Survey Data Post-Survey Data 




I am aware of who should be 
screened for chlamydia regularly 
1.67 1.11 2.00 1.41 
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The mean score was 1.67 on the pre-survey with 8 providers (66.67%) who “strongly 
agree”, 2 providers (16.67%) who “somewhat agree”, and 2 providers (16.67%) who “somewhat 
disagree”.  On post-survey, the mean score was 2.00 with 3 providers (50%) who “strongly 
agree”, 2 providers (33.33%) who “somewhat agree”, and 1 provider (16.67%) who “strongly 
disagree”.  Standard deviation rose from 1.11 to 1.41 in the post-survey indicating that not only 
did providers feel less comfortable knowing who should be screened for chlamydia, they were 
also less consistent with their self-assessments.  This question resulted in a worsening mean 
score after the education module, suggesting that the education module either confused providers 
or they disagreed with the information.  Likely, the lower score is partially caused by the lower 
overall number of providers reporting, in combination with 1 provider who reported feeling less 
confident about who should be screening for chlamydia then before the education. 
Question 5 – I understand how to test for chlamydia. 
The fifth question gauges how well providers know what the testing options are when 
screening or testing for chlamydia.  Research demonstrates that the best method to test for 
chlamydia is a urine sample using the first part of the urine (first catch urine).  
Survey Questions Pre-Survey Data Post-Survey Data 




I understand how to test for 
chlamydia 
1.42 1.11 1.33 0.47 
  
 The mean score was 1.42 on the pre-survey with 10 providers (83.33%) who “strongly 
agree”, 1 provider (8.33%) who “somewhat agree”, and 1 provider (8.33%) who “strongly 
disagree”.  On post-survey, the mean score was 1.33 with 4 providers (66.67%) who “strongly 
agree”, and 2 providers (33.33%) who “somewhat agree”.  This question resulted in an improved 
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mean score suggesting the education module helped increase providers knowledge and comfort 
level with testing options for chlamydia screening.  Standard deviation improved from 1.11 on 
the pre-survey to 0.47 on the post-survey, indicating participants were also more consistent with 
their knowledge and level of comfort regarding chlamydia testing.   
Question 6 – I know how to treat chlamydia infection. 
The sixth question evaluates how well providers know how to treat chlamydia infection. 
Research demonstrates that the standard treatment for chlamydia consists of a one-time dose of  
azithromycin at a dose of 1 gram.  
 
Survey Questions Pre-Survey Data Post-Survey Data 




I know how to treat chlamydia 
infection 
1.83 1.14 1.33 0.47 
 
 The mean score was 1.83 on pre-survey with 6 providers (50%) who “strongly agree”, 4 
providers (33.33%) who “somewhat agree”, 1 provider (8.33%) who “neither agree or disagree”, 
and 1 provider (8.33%) who “strongly disagree”.  On post-survey the mean score was 1.33 with 
4 providers (66.67%) who “strongly agree” and 2 providers (33.33%) who “somewhat agree”.  
This question resulted in an improved mean score suggesting the education module helped 
increase provider knowledge and comfort level with how to treat chlamydia infection.  Standard 
deviation improved from 1.14 on the pre-survey to 0.47 on the post survey indicated providers 
were also more consistently comfortable with knowing how to properly treat chlamydia 
infection. 
Question 7 – I understand how to address sexual partners and testing for cure. 
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The seventh question evaluates provider knowledge related to medically supporting 
sexual partners as well as how/when a provider would test to confirm the infection is cured. 
Research demonstrates that the providers may order treatment for sexual partners without an 
office visit, that patient and partner should refrain from sex for 7 days after treatment, and that 
because the rate of reinfection is so high retesting should occur after 3 months. 
Survey Questions Pre-Survey Data Post-Survey Data 




I understand how to address 
sexual partners and testing for 
cure 
1.92 0.95 1.83 0.69 
 
 The mean score was 1.92 on pre-survey with 5 providers (41.67%) who “strongly agree”, 
4 providers (33.33%) who “somewhat agree”, 2 providers (16.67%) who “neither agree nor 
disagree”, and 1 provider (8.33%) who “somewhat disagree”.  On post-survey the mean score 
was 1.83 with 2 providers (33.33%) who “strongly agree”, 3 providers (50%) who “somewhat 
agree”, and 1 provider (16.67%) who “neither agree nor disagree”.  This question resulted in 
improved mean score suggesting the education module helped increase provider knowledge and 
comfort level with addressing the sexual partners of patients with chlamydia infection as well as 
testing for cure.  Standard deviation also improved from 0.95 on the pre-survey to 0.69 on the 
post-survey indicated providers felt more consistent in their knowledge and understanding of 
how to address sexual partners and chlamydia retesting. 
For this project the electronic notification system had a strong effect on screening rates 
over the one-year period, resulting in an increase from 14% to 50%.  Konerman et al. (2017) 
implemented a similar notification system in order to screen for Hepatitis C in high-risk 
populations and demonstrated an increase from 7.6% to 72% over a one-year period.  
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Furthermore, Tapp et al. (2020) incorporated a notification system within a large healthcare 
system, including 12 primary care practices, and saw increases in screening rates for both 
Hepatitis C (3.2% to 22.7%) as well as HIV (6.2% to 11.3%).  The utilization of electronic 
notification systems in the literature has consistently shown beneficial results and the use of this 
intervention to address chlamydia screening demonstrated similar and significant positive results. 
 The goal of this project was to increase screening rates to at least 60% and there are 
several potential reasons for not reaching this goal.  The goal was broken down to consist of 50% 
coming as a result of the electronic notification system and 10% coming from the educational 
component; a review of the educational survey data demonstrates minimal to no effect in 
chlamydia knowledge for providers which suggests the educational intervention or the survey 
methods needs review and improvement.  The electronic notification system was activated at the 
same time as a number of other screening notifications, potentially resulting in something which 
can be referred to as notification overload.  During implementation of EPIC, previous screening 
and vaccination information was not incorporated, leaving providers inundated and requiring 
manually addressing multiple screening notifications for each and every patient.  As patients 
often come with a primary complaint, providers are often faced with the option of cancelling the 
reminder and foregoing the appropriate screening test.  This can happen for a number of reasons; 
providers may be running behind schedule, the patient may have several complaints or be a 
complex patient, or the provider may just prioritize one of screening needs (i.e., depression).   
Thus, future projects might benefit by addressing notification overload such as allocating 
resources to ensure screening and vaccination data is imported from previous EMRs, manually 
entered and updated prior to activation, or giving providers the option to reset the notification so 
that it notifies them again at the next appointment.   
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Discussion 
Despite a review of national data that shows screening for chlamydia in the high-risk 
population is occurring at a rate of approximately 50%, an assessment performed at an FQHC 
providing primary care to underserved populations in California demonstrated screening rates to 
be at 14%.  During project research and development, the incorporation of an electronical 
notification system within the medical record was identified as a useful method to bring 
screening rates close to national averages, while the inclusion of knowledge sharing and 
education strongly suggested that screening rates could be boosted at least temporarily above 
national averages.  Thus, the aim of this project was to improve screening rates for chlamydia in 
high-risk populations from 14% to at least 60% within a 12-month period, and as this project 
resulted in an overall increase of 50%, we did not successfully achieve our goal.   
Key findings from this project included that the incorporation of an electronic notification 
system resulted in significant increases to screening rates, independent of supportive activities 
such as education modules, collecting surveys, and raising awareness.  This aspect of the 
intervention contributed most importantly to the success of the overall change seen in this 
project.  An unexpected and key finding came from the survey data which demonstrated areas of 
minimal improvements to knowledge and confidence.  More surprising was that one of the 
questions, related to identifying who should be screened for chlamydia regularly (i.e., identifying 
high-risk populations), resulted in less knowledge and lower confidence after the education.  We 
assume that these results occurred as a result of education material that was not presented in a 
clear and concise manner, without follow-up, discussion, or question and answer.  Staff likely 
had preconceived notions, misinformation, or questions regarding high-risk populations for 
chlamydia screening, and the education module did not provide enough information.  
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Anecdotally, it was observed that a type of notification overload was occurring during the project 
and this was neither considered or prepared for.  Numerous electronic notifications were 
activated simultaneously upon software release as the incorporation of screening history into the 
new EMR never occurred.  Therefore, each patient arriving in clinic would have an average of 6 
electronic notifications including depression, smoking, and obesity.  To resolve this properly the 
provider would have to open the old charting system alongside the new system, evaluate each 
notification and update the new system accordingly.  The issue of notification overload could 
have been avoided through the incorporation of historic screening information into the new EMR 
or through the organization’s establishing each patient’s initial visit after implementation of the 
EMR as a 30-minute visit to provide ample time for providers to update charts manually in real-
time.    
An important implication from this project for the advanced nursing practice is that 
routinely assessing organizational outcomes can help identify gaps in care, and can reveal 
opportunities to improve patient outcomes.  This project began through a need’s assessment, 
where data on a number of communicable diseases was assessed and compared against 
guidelines as well as national averages.  An additional implication is that the use of a notification 
system within the electronic medical record has benefit that translates beyond chlamydia and can 
be incorporated for any number of evolving and currently identified screening criteria.  This 
solution could also benefit other recommended screening guidelines such as obesity, depression, 
other sexually transmitted infections, and cancer as well as to remind providers about 
recommended vaccinations.  Such a system could be centrally updated to reflect changes in any 
of the guidelines, such as the American Cancer Society’s recent change for colorectal cancer 
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screening in men, to lower the age for screening to begin at 45 years old (American Cancer 
Society, 2021). 
Providing an educational component for staff member, including chlamydia knowledge, 
screening guidelines, and treatment modalities can be beneficial for raising awareness and 
keeping staff updated of potentially evolving changes in the standards of practice.  Results from 
this project’s survey data shows that the educational component of this project had a minimal 
and potentially negative impact on improving self-reported provider knowledge or confidence in 
certain aspects of screening and treating this population.   
The use of an electronic notification system in combination with staff education has been 
suggested in literature as an effective method for raising awareness while increasing screening 
rates for a number of diseases within the primary care setting.  This solution was incorporated, 
modified for fit, form and function, and implemented within a primary care setting to enhance 
chlamydia screening.  The results of this project demonstrate that screening rates can be 
significantly increased by use of this intervention bundle, though staff education and self-
confidence was only minimally impacted.  
Next steps for this project involve expanding to other clinic sites in order to provide 
strength to and validate the effects of the intervention.  Additionally, the educational component 
of the project could be reviewed, revised, and re-evaluated utilizing video conferencing or in-
person sessions for improved effect.   
Interpretations 
The purpose of this project was to enhance awareness and knowledge regarding 
chlamydia, and to implement a solution that will lead to improved screening rates in high-risk 
populations.  Despite survey data suggesting that minimal improvements to chlamydia 
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knowledge were realized after the educational intervention, an interpretation of the design of the 
education material as well as the robustness of the survey data collection should be considered.  
The most successful outcome of this project came from evaluating the percentage of people who 
are being screened for chlamydia after implementing the intervention.  Post-intervention 
screening rates more than tripled, and now align with national screening rate data suggesting the 
project was effective.  
In evaluating the survey data there is a noted lack of safeguards in place to ensure that 
access to the post-intervention survey was only available to 1) those who completed the pre-
intervention survey and 2) those who watched the educational intervention. While there is no 
evidence that this occurred, it was possible for new participants, as well as those who did not 
complete the educational intervention, to access the post-intervention survey and provide data 
which could have skewed results.  To address this shortcoming, a recommendation would be to 
assign randomized identification numbers to participants, a feature available in the Qualtrics 
survey software, which validates consistency with participants, allowing for more granularity in 
the review of data and leading to a better understanding of the true effect of this intervention.  
Alternatively, the educational intervention could have been completed in person as a presentation 
and included both a participation sheet as well as a question-and-answer period to reinforce the 
education.  Shelter-in-place orders resulting from Covid-19 would have made this an unlikely 
solution.  Additionally, the lower than anticipated turnout in post-survey respondents (n=6) 
limits the generalizability of the results.   
Limitations 
 The greatest limitation to this project came about as a result of the Covid-19 pandemic 
which reached the United States in 2020 and reshaped the primary healthcare landscape.  
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According to the County of Alameda, shelter-in-place orders were issued to the general public 
starting March 16, 2020 and had an emphasis on staying at home, leaving only for vital services, 
and maintaining social distancing (County of Alameda, 2020).  Shortly after shelter-in-place 
order were issued this primary care clinic site was able to incorporate technology for the purpose 
of facilitating tele-health patient visits.  While this allowed for the management of chronic 
conditions and addressing of new complaints, the ability to facilitate ongoing healthcare 
screenings is unknown.  According to Alexander et al. (2020), primary care visits decreased by 
21.4% during the second quarter of 2020.  One could infer there were also less labs and 
screening tests ordered to allow for better focus on patient complaints during this time.  As data 
for the project was collected up through June 2020, a resulting three months of information based 
on telehealth visits is included, and has likely impacted the results of this project.  The 
significance of this impact is unclear. 
An obstacle to the effective rollout of the CSIP was related to notification overload, the 
large number of notifications within the EMR that occur during the workday, and the impact it 
would have on the effectiveness of this project.  According to a 2016 article in Healthcare IT 
News, information overload is a concern because new types of notifications can be easily created 
within the electronic medical record (McCarthy, 2016).  As a result, practitioners are 
experiencing notifications both asynchronously (inbox-like format) and synchronously (pop-up 
messages) for an increasing number of care related activities, including screenings, vaccinations, 
test results, response to referrals, requests for medication refills, and messages from other 
healthcare professionals.  Future research would benefit from measuring the impact notification 
overload has on effective electronic notification as well as systems that may help address it.  One 
approach to addressing this limitation may be having the electronic medical record automatically 
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enter the appropriate screening order when triggered by electronic notification and allowing the 
provider to manually cancel the order if the patient chooses to forgo screening. 
Perhaps an extenuating condition of the observed notification overload is that 
practitioners within the primary care setting are not provided additional time or compensation for 
addressing notifications, with the required time and efforts caused by these notifications not 
being accounted for.  Within the primary care location of this project, the organizational business 
plan allocates 15-minute time slots for appointments in order to support patient’s primary 
complaint.  In addition to addressing primary complaints, providers also perform a review of 
systems, elicit a medical history, address all pertinent notifications, address any secondary 
complaints, and answer questions.  In practice, providers are becoming more often left to 
prioritize aspects of care within appointment time frames and the true potential of novel ideas 
such as electronic notifications could be limited by a lack of time.  
Conclusion 
Screening for disease in at-risk populations is an effective method to reduce comorbidity 
and improve health and wellness within the community.  However, there are a number of 
challenges for screening in a busy primary care setting, with additional challenges existing for 
screening adolescents and young adults.  Several organizations have developed evidence-based 
guidelines that call for annual screening to identify chlamydia infection for sexually active 
females aged 13 to 24 years old.  While organizations strive for 100% screening, data shows that 
primary care is averaging approximately 50% screening rates nation-wide.  Within an FQHC-
based primary care clinic site, operating in an underserved area of Oakland CA, screening rates 
were found to be at 14%.  By implementing a bundle that includes an electronic notification 
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system with education module, screening rates for this high-risk population were shown to 
improve to 50%, which brings this clinic screening rates in line with the national average. 
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Appendix C.1 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 
Keegan, M., 2014, 
Journal of Clinical 
Outcomes 
Management, 
Volume 21, Issue 1, 
pp 30-38 






















Barriers – One 








Screening –  




1,598 received no 
intervention 
 
N = 17 high school 
8 high schools had 
intervention 
9 high schools had 
no intervention 
 










Barriers – Two 




Management – 2002 


















































Screening – The 
USPSTF adopted 
annual screening 
based on the 








allows for vaginal 




Barriers – Included 





Treatment – 1 gram 
of Azithromycin 
PO once is 
effective at treating 
infection. 
 
(RCT = Randomized Controlled Trial, USPSTF = United States Preventative Services Task Force, NAAT = Nucleic Acid Amplification Test, PO = oral 
administration) 
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Appendix C.2 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 
Guy, R., 2011, 
BMC Infectious 
Disease, Volume 
11, Article 211, pp 
1-13 
To provide an 
updated synthesis of 
studies examining 













Key words included 
chlamydia, testing 
or screening, 
intervention or trial, 
and general practice 
or primary care. 
 
96 total articles 
were identified 
 
81 articles were 
excluded based on 
exclusion criteria 
 
15 articles were 




total tests done, and 
mean number of 
tests per physician. 






screening at a P-
value of 0.05. 
Interventions for 
increasing 









to a PAP smear.  
 
Integration of 
computer alerts.  
 
Funding for free 














(PAP = Papanicolaou smear) 
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Appendix C.3 – Research Evaluation Table 
Citation Aims Design & 
Methodology 







13, Article 130, pp 
1-19 
To identify barriers 
and facilitators to 
chlamydia testing 
for young people in 
general practice, 
and to map these 

















is a theory of 
behavior that can 






through April 2018. 
 








testing in general 
practice. 
 
39 papers met 
including criteria 
 
14 focused on 
patients 
 











conclusion of each 
study. 
 
COM-B lies at the 
center of the 
Behavior Change 








Each paper was 
assessed using the 
Critical Appraisal 
Skills Programme 









were then classified 
into six sub-




Lack of knowledge 
















Concern for infection 
Training/use of 
scripts 





(MA = Medical Assistant, RN = Registered Nurse) 
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Appendix C.4 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 
Wong, W., 2019,  
Epidemiologic 
Reviews,  
Volume 41, Issue 1,  







related to the 
heterogeneity of 
interventions which 
makes it difficult to 
determine which 















in English after 
2000. 
 
Interventions had to 
focus on chlamydia 
screening and have 
one or more of the 
following outcome 
measures: number 




rate for chlamydia 
 
 
200 studies met 
inclusion criteria 
 
21 reviews were in 




settings, type of 
testing, number of 
people tested, 
prevalence, number 
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Appendix C.5 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 




Volume 90, Issue 3,  
Pages 188-194  
 














Practices may tend 






The modified Zelen 
design overcomes 
potential bias by 
not informing any 
participants that 
they participating 









between 2009 and 
2011. 
 
80 practices to 




based on the theory 




to influence social 


















Aggregate data by 
month, age and 
gender for each 
registered GP on all 
chlamydia 
screening tests in 
the study area were 
used to assess the 
absolute and 
relative change in 








Testing rates across 
all practices with the 
intervention saw an 
increase from 2.43 to 
4.34 per 100 patients, 
compared to the 
control group with 
saw an increase from 





intervention led to a 
76% increase in 
screening rates across 
all practices. 
(GP = General Practice)  
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Appendix C.6 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 
Karas, D., 2018,  
Clinical Pediatrics,  
Volume 57, Issue 
14,  
Pages 1638 -1641  
 
To identify the 
impact of a CDS 
tool on the 
screening rates for 
chlamydia among 
female patients 





the impact of pop-
up alerts and 
education on 
chlamydia 










is a network of 27 
pediatric primary 
care offices in 
urban, suburban, 
and rural areas. 
 
All practices are 






the ages of 13 and 
21 years old. 
 
A pop-up alert to 
notify providers 
that a patient was 














distributed to the 
medical offices for 
2 years 
 
An evaluation of 
medical record 
information looking 












The proportion of 
screened patients 
increased from 230 to 
561 which represents 
a 109% increase 
(CDS = Clinical Decision Support, EHR = Electronic Health Record) 
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Appendix C.7 – Research Evaluation Table 
Citation Aims Design & 
Methodology 
Sample & Setting Variable  Measurement & 
Analysis 
Findings 
Ursa, A., 2019, 
Chinese General 
Practice, Volume 
22, Issue 25, Pages 
3028 - 3034 
The aim of this 
paper is to conduct 
a case study 
looking at the use 
of Plan-Do-Check-
Adjust (PDCA) as 





women aged 16 to 
24 years old 
 
 
Plan, Do, Check, 
Adjust model and 




















System, over a one-
year period from 




were women aged 
16 – 24 who were 
sexually active. 
Education material 
and a clinical 
decision support 




material was for 













tool was an alert 
that displayed in an 






from the EMR as 
well as interviews 
with clinicians and 
staff to understand 
the current state 
and challenges of 
chlamydia 
screening.   
 
Screening improved 
from 29% to 60% 
within 8 months at the 
pilot clinic site.   
 
Four years after the 
intervention screening 
rates ranged from 
32% - 63% for 16 to 
17 years old and 49% 
- 80% for 18 to 24 
years old 
 
QI projects benefit 
from the step-by-step 
process outlined in 
the PDCA and Model 
for Improvement 
theories to effectively 
tackle challenges and 
improve outcomes. 
(PDCA = Plan, Do, Check, Adjust, EHR = Electronic Health Record)  
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Appendix D – Gap Analysis 
 
Chlamydia Screening Improvement Project Gap Analysis 
Current State Best Practice Proposed Solution 
Potential lack of staff knowledge 
regarding aspects of chlamydia screening 
and treatment, as well as potential lack of 
confidence to effectively discuss and 
answer questions with patients 
 
Provide periodic and updated chlamydia 
education to staff members including 
screening guidelines, symptoms, 
treatment, and common questions 
 
Develop education module for staff to 
teach and update knowledge regarding 
chlamydia screening and treatment 
Cultural and educational barriers to 
effective chlamydia screening in the 
clinical setting 
 
Staff to effectively communicate and 
educate patients, answer questions about, 
and recommend annual screening for 
high-risk patients 
Create survey for staff members to 
measure knowledge and confidence in 
discussing chlamydia in the clinic setting, 
both pre and post education  
 
Absence of formal system to remind 
providers of high-risk population and 
frequency for chlamydia screening 
 
Availability of a convenient and 
accessible reminder system for staff to 
identify high-risk populations and 
chlamydia screening guidelines 
Initiate electronic notification/reminder 
system to alert providers when clinic 
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Appendix F – Work Breakdown Structure 
 
Level 1 Level 2 Level 3 
1. Chlamydia Screening 
Improvement Project (CSIP) 
1.1  Initiation 1.1.1 Evaluation of Baseline Data & Recommendations 
1.1.2 Develop the Business Case 
1.1.3 Develop the Project Charter 
 
1.2  Planning 1.2.1 Create Aim Statement 
1.2.2 Determine Project Team 
1.2.3 Define Electronic Notification and Test in Virtual “Playground” 
1.2.4 Develop Education Module and Survey Material 
1.2.5 Develop Project Plan 
1.2.6 Project Plan Approval 
 
1.3  Execution 1.3.1 Project Kickoff Meeting 
1.3.2 Implement Software System Upgrade 
1.3.3 Evaluate Electronic Notification in Real-Time 
1.3.4 Test Report System for Accumulation of Data Verification 
1.3.5 Conduct Pre-Survey 
1.3.6 User Training / Education 
1.3.7 Conduct Post-Survey 
1.3.8 Evaluation of Post-Intervention Data 
 
1.4  Closeout 1.4.1 Project Review Meeting 
1.4.2 Document Project Plan with Results and Lessons Learned 
1.4.3 Update Files/Records 
1.4.4 Gain Formal Acceptance 
1.4.5 Archive Files/Documents 
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- Easy to implement
- Good staff experience
- Uses technology
WEAKNESSES
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Appendix I – Cost Analysis 
 
Direct Expense Projected Cost (-) Project Savings (+) 
Development   
Education Module $480  
Survey $480  
Activate electronic reminders $0  
   
Training   
Education $2,700  
Survey $2,700  
Total Projected Costs $6,360  
   
Indirect Costs   
Treatment for PID  $1,995 
Estimated annual # of cases  147 
Total Projected Savings  $29,326.50 
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Appendix J – Chlamydia Screening Improvement Project Pre and Post Survey 
 
 
1. I am comfortable discussing chlamydia with a patient 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
2. I know what the most common symptoms of chlamydia are 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
3. I can identify the high-risk population for chlamydia infection 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
4. I am aware of who should be screened for chlamydia regularly 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
5. I understand how to test for chlamydia 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
6. I know how to treat chlamydia infection 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
7. I understand how to address sexual partners and testing for cure 
(Strongly Agree) 1  2  3  4  5 (Strongly Disagree) 
 
 
 
 
 
